logo
What is blue light and can it really ruin your sleep? We asked the experts

What is blue light and can it really ruin your sleep? We asked the experts

Tom's Guide06-06-2025

I'll be the first to admit, I spend more time than I'd like scrolling in the evening. I do my best to follow a relaxing screen-free nighttime routine, but some nights the screentime gets one over me.
Luckily, I sleep on one of this year's top-rated mattresses and get plenty of fresh air and movement during the day, so this evening light exposure doesn't completely ruin my sleep. However, I'm curious about the impact blue light has on my overall sleep quality.
Online advice around blue light is conflicting. Some sources say it's sure to ruin your sleep, while others say it's not so bad.
So, I've dug into studies and reached out to Dr. Michael Gradisar, head of sleep science at Sleep Cycle, and insomnia and sleep therapist Dr. Anna Joyce to set the record straight. Here's what these two experts want you to know about blue light and sleep...
Blue light is part of the visible light spectrum and accounts for about one-third of all light we see as humans.
This type of light influences alertness, hormone production and sleep cycles.
Blue light comes naturally from the sun, the biggest source of blue light we consume, but it can also come from artificial sources like smartphone screens, televisions and fluorescent and LED lights.
Bright light, i.e blue light, interferes with the circadian rhythm by suppressing production of the sleep-inducing hormone melatonin.
When the brain identifies light, it sends signals to the body telling it to be alert rather than sleepy. So, in theory, blue light exposure in the evening should delay sleep onset.
On the flip side, it helps us feel alert come morning. Hence, exposing yourself to natural daylight first thing is a key tip for fighting morning grogginess and getting up and at 'em, which in turn helps us sleep better at night.
The common assumption is blue light is bad news for sleep — and with right reason. A 2022 systematic review by Swiss researchers of studies investigating the influence of blue light exposure on sleep, performance and wellbeing concluded blue light could have negative effects such as a decrease in sleep quality and sleep duration.
However, recent research by The Conversation suggests blue light isn't as bad for sleep as we've previously been led to believe.
Sleep experts from Sweden, Australia and Israel found blue light exposure only delayed sleep by 2.7 minutes — hardly substantial.
Experts, including Dr. Gradisar and Dr. Joyce, now agree that although light from screens does delay melatonin release, it only makes a minimal difference. Light from screens just isn't bright enough to significantly affect sleep patterns.
"For blue light to meaningfully shift a person's sleep timing, the light source needs to be at least ten times brighter than what's emitted from phones, tablets, or other devices," says Dr. Gradisar.
Rather, it is our cultural inability to shut down screens at bedtime, as we're sucked into unceasing social media feeds, that impacts our sleep, particularly how long we sleep for.
Research from Dr. Gradisar shows the biggest sleep disrupter is delaying bedtime due to screen use rather than the light from the screens.
"Don't fear using screens before bed — just time them wisely," he says. "While blue light from phones is often blamed, my research has shown that the biggest disrupter is actually delaying bedtime, not the light or the content from screens themselves."
"Watching TV or listening to a podcast as a wind-down routine can be perfectly fine, especially if it helps reduce nighttime overthinking, as long as it doesn't cut into the number of hours of rest you get."
Evening blue light is pretty much unavoidable in our modern world and, as tech gurus here at Tom's Guide, we're not ones to say get rid of your gadgets altogether. Instead follow these tips for sleeping well even after your screentime fix…
When I do fall into the trap of being glued to my phone in the evening, it's certainly harder to switch off.
Be it catching up with gossip in the group chat, online shopping or a doom scroll through Instagram reels, I rarely come away from my screen feeling sleepy.
Instead I'm thinking about the breakup of a couple I've never met, contemplating whether I really need that new outfit or dreaming of that holiday destination that was made to look oh-so perfect in a 30 second video.
"The problem is that we usually use screens for engaging and alerting activities, like work, reading the news, or scrolling social media; all things which stimulate us and affect our mood," explains Dr. Joyce.
"The brain needs time to wind down in order to fall asleep so some transition time between screen use and bedtime is helpful."
Similarly, Dr. Gradisar recommends podcasts or watching TV for your bedtime digital fix instead of scrolling.
"TV is a passive device compared to phones. Many people fall asleep just fine after watching TV, with some drifting off while it's on," he says.
There's no serious harm in using screens as part of a nighttime wind-down routine — television programmes or films are a mainstay in many people's evenings.
But, as Dr. Gradisar's research shows, you need to be disciplined over your screen shut off time before bed to ensure it doesn't eat into crucial sleep time.
That means having the self-control to flick up the TikTok app or turn off Netflix rather than hit 'play next episode' when bedtime rolls around.
A 2024 study by researchers at the University of Otago concludes we should keep screens out of bed for better sleep, rather than cutting them out in the evening completely.
This enforces a cut off point for screens — i.e. use them on the sofa, but put them down once you get into bed.
You can buy blue light blocking glasses and lamps that help minimize the glare of screens and prevent blue light from interfering with sleep.
I've been using a blue light blocking clip light (on sale for $29.99/£19.99 $25.49/£16.99 at Bon Charge) to read before bed.
I've found replacing my bright bedside lamp with this dim red light has been a game changer for helping me drift off immediately after closing my book.
While the scientific studies around blue light blocking glasses are tenuous, our Tom's Guide team have tested the best blue light blocking glasses you can buy online right now.
These glasses are designed to filter out wavelengths that disrupt our circadian rhythms. Be their effectiveness placebo or not, we think they're worth trying if you're concerned about how blue light is impacting your circadian cycle. Plus, they won't break the bank.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RPI's Jacob Lee Signs in Switzerland
RPI's Jacob Lee Signs in Switzerland

Yahoo

time2 days ago

  • Yahoo

RPI's Jacob Lee Signs in Switzerland

Swiss man returns to Philadelphia hospital after life-changing double hand transplant 29-year-old Luka Krizanac from Switzerland received a double hand transplant at Penn Medicine in Philadelphia, Pennsylvania in late 2024, 17 years after losing his hands and feet to an infection that turned into sepsis. Luka visited the Hospital of the University of Pennsylvania again this June and says the miracle surgery has changed his and his family's life. 1:25 Now Playing Paused Ad Playing

Brenus Pharma and InSphero Have Developed 3D Tumor Spheroids Mimicking
Brenus Pharma and InSphero Have Developed 3D Tumor Spheroids Mimicking

Business Wire

time3 days ago

  • Business Wire

Brenus Pharma and InSphero Have Developed 3D Tumor Spheroids Mimicking

LISBON, Portugal--(BUSINESS WIRE)--Brenus Pharma, a French biotech developing next-generation first-in-class immunotherapies, and InSphero, a Swiss leader in 3D cell-based assay technologies, presented promising data at the European Association for Cancer Research 2025 annual congress. These data confirm the use of 3D tumor spheroids for potency testing of STC-1010, Brenus' lead candidate for colorectal cancer. 'This collaboration has enabled us to assess the highly representative and scalable 3D model into our SGC platform. It's a major step forward in our ability to assess potency and accelerate the development of STC-1010 and future candidates.' Benoit Pinteur Share Funded through the EUROSTARS program, the collaboration led to vitrified 3D colorectal cancer spheroids using tumor cell lines co-cultured with fibroblasts. The vitrification method preserves morphology, stromal integrity, and viability after thawing, enabling realistic evaluation of STC-1010's therapeutic potential under conditions mimicking in vivo human tumors. Previous studies showed that STC-1010 antigens were effectively processed by monocyte-derived dendritic cells (mMo-DCs), activating CD8+ T cells. These T cells induced apoptosis in both 2D and 3D colorectal cancer models and released anti-tumor cytokines (IFNγ and Granzyme B). These data reinforce the therapeutic potential of STC-1010. ' This collaboration has enabled us to assess the highly representative and scalable 3D model into our SGC platform. It's a major step forward in our ability to assess potency and accelerate the development of STC-1010 and future candidates.' Benoit Pinteur, CSO of Brenus Pharma. ' We are proud to support Brenus with our cryopreserved 3D tumor models. This work illustrates how advanced in vitro systems can bring immunotherapies closer to clinical reality.' Jan Lichtenberg, CEO of InSphero. About Brenus Pharma Brenus Pharma unlocks the potential of immuno-oncology by generating first-in-class immunotherapies that initiate a multi-specific in vivo immune response against tumors. Their proprietary 'off-the-shelf' Stimulated-tumor-Ghost-Cells (SGC) platform mimics patients' tumor cells and makes them visible to the immune system to anticipate, target, and destroy these cells as they appear. Brenus aims to shift the oncology paradigm by making patients active participants in their treatment.

Roman Josi diagnosed with POTS. What it means and when Predators captain could return
Roman Josi diagnosed with POTS. What it means and when Predators captain could return

USA Today

time3 days ago

  • USA Today

Roman Josi diagnosed with POTS. What it means and when Predators captain could return

Roman Josi diagnosed with POTS. What it means and when Predators captain could return The Nashville Predators have released a statement regarding captain Roman Josi's recent diagnosis of postural orthostatic tachycardia syndrome. "Roman Josi was diagnosed with POTS (postural orthostatic tachycardia syndrome) toward the end of the 2024-25 season," the statement reads. "He has been undergoing treatment since that diagnosis and is progressing exceptionally well," In a recent interview with Blick, a Swiss digital media company, Josi revealed that he was diagnosed with POTS after investigating the after effects of a head injury. The injury occurred during a Feb. 25 game against the Florida Panthers, when Sam Bennett hit Josi into the wall, causing his head to hit the glass. What is POTS and when will Roman Josi return to Predators? After dealing with headaches, dizziness and lightheadedness, Josi said the diagnosis was made during a post-concussion check-up. POTS is a condition in which one suffers an increased heart rate after standing up and can be accompanied by dizziness, fatigue and brain fog, according to Johns Hopkins Medicine. Since his diagnosis, Josi has been given medicine for treatment and expects to be able to play the 2025-26 season. 'I've been feeling much better since then," he told Blick, via Google Translate. "I've regained the belief that I'll be 100 percent fit again and can fully attack with Nashville and the Swiss national team next winter.' The Predators' statement adds that the organization feels Josi will be fine to play in the 2025-26 season. "We concur with Roman that with continued management and treatment, he can return to the ice for the 2025-26 season and continue his elite hockey career," the statement read. Josi, who missed the final 25 games of the season with a concussion, scored nine goals and had 29 assists in 53 games for Nashville in 2024-25. The 35-year-old captain is the Predators' all-time leader in points (724) and games played (962). OLYMPIAN: Roman Josi to represent Switzerland, Juuse Saros on Finland roster for 2026 Olympics Predators reacquire Erik Haula The Predators have acquired forward Erik Haula from the New Jersey Devils in exchange for a fourth-round pick (2025) and defenseman Jeremy Hanzel. Haula, 34, scored 11 goals and 10 assists for the Devils last season. In his 12-year career as a winger and center, Haula has 153 goals and 184 goals in 759 games for seven different teams. The trade brings Haula back to Nashville, where he spent the 2020-21 season. That year, he scored nine goals and 12 assists in 51 games with the Predators before leaving in free agency for the Boston Bruins. Haula is in the final year of a three-year contract he signed with New Jersey in 2023. He is owed $3.15 million for the 2025-26 season, after which he will be an unrestricted free agent. After accounting for Haula's $3.1 million cap hit, the Predators will have $14.2 million in cap space for the 2025-26 season, according to PuckPedia. Alex Daugherty is the Predators beat writer for The Tennessean. Contact Alex at jdaugherty@ Follow Alex on X, the platform formerly called Twitter, @alexdaugherty1. Also check out our Predators exclusive Instagram page @tennessean_preds.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store